Form D · Private Equity Fund
KKR Health Care Strategic Growth Fund II SCSp
New York, NY · CIK 0001831554
Offering snapshot reported Feb 11, 2022 · SEC filing
- Reported sold
- $3.14B Offering amount: $3.14B
- Investors reported
- 123 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 20, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
- Reported investors0 → 123
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 11, 2022 | Amendment | $3,139,307,000 | No comparison | 123 | SEC filing |
| Nov 19, 2020 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Pooled investment fund, Other
- Exemptions
- 06b, 3C, 3C.7
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $11M (estimated)
- Finders' fees
- $0
- Form D file number
- 021-381062
Total commitments to this fund and its parallel vehicles are $4,018,082,000.
Limited Partner Interests
The figure disclosed above reflects estimated amounts expected to be paid to placement agents in respect of the offering of Limited Partnership interests of the Issuer
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Samsung Securities Co., Ltd. | None | |
| UBS Financial Services, Inc. | 8174 | |
| Bank of Singapore Limited | None | |
| Morgan Stanley Smith Barney LLC | 149777 | |
| PAS Advisory Services Pty Ltd | None | |
| Hanwha Investment & Securities Co., Ltd. | None | |
| OCP Fund Management Inc. | None | |
| OCP Fund Management LP | None | |
| Citi Private Advisory, LLC | 153777 | |
| Citigroup Global Markets Inc. | 7059 | |
| Citibank Canada Investment Funds Limited | None |
Source: Form D, filed Feb 11, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
The linked fund shows its most recently reported ADV details.
Matched by reported Form D file number
KKR HEALTH CARE STRATEGIC GROWTH FUND II SCSP
Investment adviser: KOHLBERG KRAVIS ROBERTS & CO. L.P.
- Gross asset value
- $5.22B
- Beneficial owners
- 153
- ADV minimum commitment
- $0
Reported in Form ADV on Sep 25, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.
Service providers
Provider details
- Annual audit
- Yes
- Prime brokers
- No
- Custodians
- Yes
- Administrator other than the adviser
- Yes
- External marketing
- Yes
DELOITTE & TOUCHE LLP
PCAOB 34
ICAPITAL SECURITIES, LLC
CRD 171061 · SEC 8-69443
MORGAN STANLEY
CRD 149777 · SEC 801-70103
UBS FINANCIAL SERVICES INC.
CRD 8174 · SEC 801-7163
Filing source
Form ADV 2133354 · Sep 25, 2026 · Schedule D 7.B.(1), fund 805-9543719806
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert N/A Antablin | Executive |
| Jason N/A Carss | Director |
| Steven N/A Codispoti | Director |
| Terence N/A Gallagher | Director |
| Hadi N/A Husain | Executive |
| Stephen N/A Jordan | Executive |
| Scott N/A Karnas | Executive |
| Philip N/A Kim | Executive |
| N/A N/A Kkr Associates Hcsg Ii Sc Sp | Promoter |
| N/A N/A Kkr Hcsg Ii S.A R.L. | Promoter |
| Joan N/A Lacagnina | Executive |
| Stefan N/A Lambert | Director |
| Christopher N/A Lee | Executive |
| Max N/A Lin | Executive |
| Michael N/A Longo | Executive |
| Jennifer N/A Mc Groarty | Executive |
| Adam N/A Nowak | Executive |
| Ali N/A Satvat | Executive |
| Mary N/A Shaw | Executive |
| Edward N/A Valentino | Executive |
| Thomas N/A Weber | Director |
| Alisa N/A Wood | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:New York, NY, 10001